Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
2.
Microbiome ; 11(1): 12, 2023 01 20.
Article in English | MEDLINE | ID: mdl-36670449

ABSTRACT

BACKGROUND: The plasmid-mediated resistance gene mcr-1 confers colistin resistance in Escherichia coli and paves the way for the evolution to pan-drug resistance. We investigated the impact of mcr-1 in gut colonization in the absence of antibiotics using isogenic E. coli strains transformed with a plasmid encoding or devoid of mcr-1. RESULTS: In gnotobiotic and conventional mice, mcr-1 significantly enhanced intestinal anchoring of E. coli but impaired their lethal effect. This improvement of intestinal fitness was associated with a downregulation of intestinal inflammatory markers and the preservation of intestinal microbiota composition. The mcr-1 gene mediated a cross-resistance to antimicrobial peptides secreted by the microbiota and intestinal epithelial cells (IECs), enhanced E. coli adhesion to IECs, and decreased the proinflammatory activity of both E. coli and its lipopolysaccharides. CONCLUSION: Overall, mcr-1 changed multiple facets of bacterial behaviour and appeared as a factor enhancing commensal lifestyle and persistence in the gut even in the absence of antibiotics. Video Abstract.


Subject(s)
Escherichia coli Infections , Escherichia coli Proteins , Animals , Mice , Escherichia coli/genetics , Symbiosis , Escherichia coli Proteins/genetics , Drug Resistance, Bacterial/genetics , Anti-Bacterial Agents/pharmacology , Escherichia coli Infections/microbiology , Microbial Sensitivity Tests
3.
Molecules ; 28(1)2022 Dec 22.
Article in English | MEDLINE | ID: mdl-36615280

ABSTRACT

The development of 64Cu-based immuno-PET radiotracers requires the use of copper-specific bifunctional chelators (BFCs) that contain functional groups allowing both convenient bioconjugation and stable copper complexes to limit in vivo bioreduction, transmetallation and/or transchelation. The excellent in vivo kinetic inertness of the pentaazamacrocyclic [64Cu]Cu-15-5 complex prompted us to investigate its potential for the 64Cu-labelling of monoclonal antibodies (mAbs), compared with the well-known NODAGA and DOTA chelators. To this end, three NODAGA, DOTA and 15-5-derived BFCs, containing a pendant azadibenzocyclooctyne moiety, were synthesised and a robust methodology was determined to form covalent bonds between them and azide-functionalised trastuzumab, an anti-HER2 mAb, using strain-promoted azide-alkyne cycloaddition. Unlike the DOTA derivative, the NODAGA- and 15-5-mAb conjugates were radiolabelled with 64Cu, obtaining excellent radiochemical yields, under mild conditions. Although all the radioimmunoconjugates showed excellent stability in PBS or mouse serum, [64Cu]Cu-15-5- and [64Cu]Cu-NODAGA-trastuzumab presented higher resistance to transchelation when challenged by EDTA. Finally, the immunoreactive fraction of the radioimmunoconjugates (88-94%) was determined in HER-2 positive BT474 human breast cancer cells, confirming that the bioconjugation and radiolabelling processes implemented had no significant impact on antigen recognition.


Subject(s)
Copper , Immunoconjugates , Humans , Animals , Mice , Chelating Agents/chemistry , Immunoconjugates/chemistry , Azides , Antibodies, Monoclonal/chemistry , Trastuzumab , Copper Radioisotopes/chemistry , Positron-Emission Tomography/methods
4.
Bioorg Chem ; 98: 103747, 2020 05.
Article in English | MEDLINE | ID: mdl-32208207

ABSTRACT

The tumor microenvironment in chondrosarcoma (CHS), a chemo- and radio-resistant cancer provides unique hallmarks for developing a chondrosarcoma targeted drug-delivery system. Tumor targeting could be achieved using a quaternary ammonium function (QA) as a ligand for aggrecan, the main high negative charged proteoglycan of the extracellular matrix of CHS, and a 2-nitroimidazole as trigger that enables hypoxia-responsive drug release. In a previous work, ICF05016 was identified as efficient proteoglycan-targeting hypoxia-activated prodrug in a human extraskeletal myxoid chondrosarcoma model in mice and a first study of the structure-activity relationship of the QA function and the alkyl linker length was conducted. Here, we report the second part of the study, namely the modification of the nitro-aromatic trigger and the position of the proteoglycan-targeting ligand at the aromatic ring as well as the nature of the alkylating mustard. Synthetic approaches have been established to functionalize the 2-nitroimidazole ring at the N-1 and C-4 positions with a terminal tertiary alkyl amine, and to perform the phosphorylation step namely through the use of an amine borane complex, leading to phosphoramide and isophosphoramide mustards and also to a phosphoramide mustard bearing four 2-chloroethyl chains. In a preliminary study using a reductive chemical activation, QA-conjugates, except the 4-nitrobenzyl one, were showed to undergo efficient cleavage with release of the corresponding mustard. However N,N,N-trimethylpropylaminium tethered to the N-1 or C-4 positions of the imidazole seemed to hamper the enzymatic reduction of the prodrugs and all tested compounds featured moderate selectivity toward hypoxic cells, likely not sufficient for application as hypoxia-activated prodrugs.


Subject(s)
Antineoplastic Agents/pharmacology , Bone Neoplasms/drug therapy , Chondrosarcoma/drug therapy , Drug Design , Neoplasms, Connective and Soft Tissue/drug therapy , Phosphoramide Mustards/pharmacology , Prodrugs/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Bone Neoplasms/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Chondrosarcoma/pathology , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Molecular Structure , Neoplasms, Connective and Soft Tissue/pathology , Phosphoramide Mustards/chemical synthesis , Phosphoramide Mustards/chemistry , Prodrugs/chemical synthesis , Prodrugs/chemistry , Structure-Activity Relationship
5.
Mol Cancer Ther ; 15(11): 2575-2585, 2016 11.
Article in English | MEDLINE | ID: mdl-27573424

ABSTRACT

To date, surgery remains the only option for the treatment of chondrosarcoma, which is radio- and chemoresistant due in part to its large extracellular matrix (ECM) and poor vascularity. In case of unresectable locally advanced or metastatic diseases with a poor prognosis, improving the management of chondrosarcoma still remains a challenge. Our team developed an attractive approach of improvement of the therapeutic index of chemotherapy by targeting proteoglycan (PG)-rich tissues using a quaternary ammonium (QA) function conjugated to melphalan (Mel). First of all, we demonstrated the crucial role of the QA carrier for binding to aggrecan by surface plasmon resonance. In the orthotopic model of Swarm rat chondrosarcoma, an in vivo biodistribution study of Mel and its QA derivative (Mel-QA), radiolabeled with tritium, showed rapid radioactivity accumulation in healthy cartilaginous tissues and tumor after [3H]-Mel-QA injection. The higher T/M ratio of the QA derivative suggests some advantage of QA-active targeting of chondrosarcoma. The antitumoral effects were characterized by tumor volume assessment, in vivo 99mTc-NTP 15-5 scintigraphic imaging of PGs, 1H-HRMAS NMR spectroscopy, and histology. The conjugation of a QA function to Mel did not hamper its in vivo efficiency and strongly improved the tolerability of Mel leading to a significant decrease of side effects (hematologic analyses and body weight monitoring). Thus, QA conjugation leads to a significant improvement of the therapeutic index, which is essential in oncology and enable repeated cycles of chemotherapy in patients with chondrosarcoma. Mol Cancer Ther; 15(11); 2575-85. ©2016 AACR.


Subject(s)
Antineoplastic Agents/pharmacology , Bone Neoplasms/metabolism , Chondrosarcoma/metabolism , Proteoglycans/metabolism , Animals , Bone Neoplasms/diagnosis , Bone Neoplasms/drug therapy , Cell Line, Tumor , Chondrosarcoma/diagnosis , Chondrosarcoma/drug therapy , Disease Models, Animal , Drug Evaluation, Preclinical , Humans , Male , Melphalan/chemistry , Melphalan/pharmacology , Molecular Imaging/methods , Optical Imaging/methods , Quaternary Ammonium Compounds/chemistry , Rats
6.
Appl Radiat Isot ; 101: 1-9, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25813000

ABSTRACT

The cartilage-targeting strategy is based on the strong affinity of quaternary ammonium (QA) functions for cartilage proteoglycans. We use a bifunctional agent containing QA moiety and a polyazamacrocycle structure able to complex technetium-99m. (99m)Tc-NTP 15-5 was selected for its high stability and its high affinity for proteoglycans in vivo. Labeling conditions of NTP 15-5 were optimized, and a lyophilized kit was developed for radiolabeling of (99m)Tc-NTP 15-5 (radiochemical yields 94.6±1.8%). (99m)Tc-NTP 15-5 was stable and resulted in favorable biological evaluations.


Subject(s)
Cartilage/diagnostic imaging , Cartilage/metabolism , Heterocyclic Compounds, 1-Ring/isolation & purification , Organotechnetium Compounds/isolation & purification , Proteoglycans/metabolism , Quaternary Ammonium Compounds/isolation & purification , Radiopharmaceuticals/isolation & purification , Technetium/isolation & purification , Animals , Cartilage Diseases/diagnostic imaging , Cartilage Diseases/metabolism , Chemistry, Pharmaceutical , Freeze Drying/methods , Heterocyclic Compounds, 1-Ring/blood , Heterocyclic Compounds, 1-Ring/pharmacokinetics , Indicators and Reagents , Organotechnetium Compounds/blood , Organotechnetium Compounds/pharmacokinetics , Quaternary Ammonium Compounds/blood , Quaternary Ammonium Compounds/pharmacokinetics , Radionuclide Imaging , Radiopharmaceuticals/blood , Radiopharmaceuticals/pharmacokinetics , Rats , Technetium/blood , Technetium/pharmacokinetics
7.
J Inorg Biochem ; 115: 36-43, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22922309

ABSTRACT

The reaction of nickel (II) chloride and bromide with 3-thiophene aldehyde semicarbazone (3STCH) and 2,3-thiophene dicarboxaldehyde bis(semicarbazone) (2,3BSTCH(2)) leads to the formation of a series of new complexes: [NiCl(2)(3STCH)(2)], [NiBr(2)(3STCH)(2)], [NiCl(2,3BSTCH(2))(H(2)O)]Cl, and [NiBr(2,3BSTCH(2))(H(2)O)]Br respectively. The crystal structures of the two ligands 3STCH, 2,3BSTCH(2) and of the complex [NiBr(2,3BSTCH(2))(H(2)O)]Br have been determined by X-ray diffraction methods. For all these complexes, the central ion is coordinated through the oxygen atom of the carbonyle and the azomethine nitrogen atom of the semicarbazone. The antifungal activity of the complexes and their corresponding ligands was evaluated against some strains of respectively, Candida albicans, Candida glabrata and Aspergillus fumigatus. The complexes with 3STCH and 2,3BSTCH(2) revealed interesting CMI(80) values specifically against C. glabrata. Cytotoxicity assay was also carried out in vitro on MRC5 cells.


Subject(s)
Antifungal Agents , Aspergillus fumigatus/growth & development , Candida/growth & development , Nickel , Organometallic Compounds , Thiosemicarbazones , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Crystallography, X-Ray , Molecular Structure , Nickel/chemistry , Nickel/pharmacology , Organometallic Compounds/chemical synthesis , Organometallic Compounds/chemistry , Organometallic Compounds/pharmacology , Thiosemicarbazones/chemical synthesis , Thiosemicarbazones/chemistry , Thiosemicarbazones/pharmacology
8.
J Org Chem ; 77(7): 3679-85, 2012 Apr 06.
Article in English | MEDLINE | ID: mdl-22423645

ABSTRACT

A series of 20 optically pure 3,4-dihydro-5H-pyrido[1',2':1,2]imidazo[4,5-d][1,3]diazepin-5-ones which form a new family of azaheterocycle-fused [1,3]diazepines were synthesized in four steps with 17-66% overall yields. The key step consists of a selective C-acylation reaction of easily accessible 2-aminoimidazo[1,2-a]pyridine at C-3.


Subject(s)
Benzodiazepines/chemistry , Benzodiazepines/chemical synthesis , Heterocyclic Compounds/chemistry , Imidazoles/chemistry , Pyridines/chemistry , Acylation , Molecular Structure , Stereoisomerism
10.
J Org Chem ; 73(15): 5989-92, 2008 Aug 01.
Article in English | MEDLINE | ID: mdl-18597528

ABSTRACT

The Duff reaction (HMTA, AcOH or TFA) was studied on substituted [6 + 5] heterocyclic compounds. This reaction provides a useful route to aldehydes for compounds bearing sensitive amide functions. It gives also access to tricyclic lactams of potential biological interest. The formation of an aminomethyl intermediate in the Duff reaction mechanism is unequivocally demonstrated.


Subject(s)
Heterocyclic Compounds/chemistry , Magnetic Resonance Spectroscopy , Molecular Structure
11.
Acta Crystallogr Sect E Struct Rep Online ; 64(Pt 6): o1003-4, 2008 May 07.
Article in English | MEDLINE | ID: mdl-21202530

ABSTRACT

The title compound, C(9)H(11)N(2)O(5) (+)·Cl(-)·H(2)O, was synthesized from (1S,2S)-2-amino-1-(4-nitro-phen-yl)propane-1,3-diol in four steps. As demonstrated by this work, no racemization occurs during this synthetic procedure. The crystal structure displays many inter-molecular hydrogen bonds between the acidic cation, chloride anions and the water mol-ecules, forming a three-dimensional network. An intra-molecular bond between the ammonium group and a hydroxyl O atom is also present.

SELECTION OF CITATIONS
SEARCH DETAIL
...